Lung-targeting LNPs were effectively used to introduce TSC2 mRNA into TSC2-null cells and suppress the mTOR pathway, resulting in improved control of tumor cell proliferation in a mouse model of pulmonary lymphangioleiomyomatosis [275]. The gene discussed is TSC2; the disease is lung lymphangioleiomyomatosis.